Arda Therapeutics
PrivateLast Round
Seed Round
May 13, 2026
Total Funding Raised
$50.5M
Company Overview
Arda Therapeutics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Series A round in October 2024.
Arda Therapeutics is a biotechnology company that develops targeted therapies aimed at eliminating pathological cells responsible for chronic diseases by utilizing single-cell data to precisely target and remove these harmful cells without impacting healthy tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arda Therapeutics Comparables
Compare Arda Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fibrocor Therapeutics | 78% | |
| Rubedo Life Sciences | 77% | |
| Mediar Therapeutics | 76% |
For institutional investors. Book with your work email.
Arda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 13, 2026 | ||||
| Series A | Oct 1, 2024 | ||||
| Seed | Jan 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| LifeLink Ventures | Series A |
| GV | Series A, Seed |
| NJF Capital | Seed |
| Gaingels | Series A |
| Valhalla Ventures | Series A |
| Two Sigma Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Grew 17% QoQ, from 18 to 21 employees.
- May 13, 2026
$50K Seed Round raised.
For institutional investors. Book with your work email.
Arda Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arda Therapeutics's valuation, stock price, and market status.
Is Arda Therapeutics a public or private company?
Arda Therapeutics is a private company.
What is the current stock price of Arda Therapeutics?
Arda Therapeutics is a private company, so its shares have no public market price. Caplight tracks Arda Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arda Therapeutics worth (valuation)?
Valuation information for Arda Therapeutics is not publicly available.
Can I buy Arda Therapeutics stock?
Arda Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arda Therapeutics's last funding round?
Arda Therapeutics's most recent funding round was Seed Round on May 13, 2026.
Who are the main investors in Arda Therapeutics?
Key investors in Arda Therapeutics include Andreessen Horowitz.
Will Arda Therapeutics IPO soon?
No public IPO plans have been announced for Arda Therapeutics.
How can I track Arda Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Arda Therapeutics's shares on secondary markets.